Eagle Pharmaceuticals, Inc.

CITADEL ADVISORS LLC EGRX

Report date

9/30/2024

Quarter

2024 Q3

Filed

11/14/2024

Shares

26,013

Value ($000)

97

Weight

0.0%

2019 Q4 - 2024 Q3 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q3	11/14/2024	97	0.0%	26,013	9/30/2024
2024 Q1	5/15/2024	229	0.0%	43,729	3/31/2024
2023 Q4	2/14/2024	376	0.0%	71,899	12/31/2023
2023 Q3	11/14/2023	4,607	0.0%	292,160	9/30/2023
2023 Q2	8/14/2023	7,651	0.0%	393,549	6/30/2023
2023 Q1	5/15/2023	4,344	0.0%	153,104	3/31/2023
2022 Q4	2/14/2023	3,323	0.0%	113,701	12/31/2022
2022 Q3	11/14/2022	4,890	0.0%	185,061	9/30/2022
2022 Q2	8/15/2022	2,902	0.0%	65,320	6/30/2022
2022 Q1	5/16/2022	2,373	0.0%	47,961	3/31/2022
2021 Q4	2/14/2022	1,075	0.0%	21,105	12/31/2021
2021 Q3	11/15/2021	2,571	0.0%	46,094	9/30/2021
2021 Q2	8/16/2021	2,119	0.0%	49,516	6/30/2021
2021 Q1	5/21/2021	3,739	0.0%	89,577	3/31/2021
2020 Q4	2/16/2021	10,944	0.0%	234,999	12/31/2020
2020 Q3	11/16/2020	13,762	0.0%	323,956	9/30/2020
2020 Q2	8/14/2020	9,398	0.0%	195,878	6/30/2020
2020 Q1	5/15/2020	358	0.0%	7,793	3/31/2020
2019 Q4	2/14/2020	216	0.0%	3,596	12/31/2019